These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


114 related items for PubMed ID: 2857053

  • 1. Effects of cyclic hexapeptide analog of somatostatin on pancreatic secretion in dogs.
    Konturek SJ, Cieszkowski M, Bilski J, Konturek J, Bielanski W, Schally AV.
    Proc Soc Exp Biol Med; 1985 Jan; 178(1):68-72. PubMed ID: 2857053
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Role of secretin and CCK in the stimulation of pancreatic secretion in conscious dogs. Effects of atropine and somatostatin.
    Konturek SJ, Konturek JW, Lamers CB, Tasler J, Bilski J.
    Int J Pancreatol; 1987 Aug; 2(4):223-35. PubMed ID: 2890695
    [Abstract] [Full Text] [Related]

  • 4. Effect of somatostatin on exocrine pancreatic secretion stimulated by pancreozymin-secretin or by a test meal in the dog.
    Kayasseh L, Gyr K, Stalder GA, Rittmann WW, Girard J.
    Horm Res; 1978 Aug; 9(3):176-84. PubMed ID: 640582
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Endogenous nitric oxide mediates pancreatic exocrine secretion stimulated by secretin and cholecystokinin in rats.
    Jyotheeswaran S, Li P, Chang TM, Chey WY.
    Pancreas; 2000 May; 20(4):401-7. PubMed ID: 10824696
    [Abstract] [Full Text] [Related]

  • 8. Effect of growth hormone-release inhibiting hormone on hormones stimulating exocrine pancreatic secretion.
    Konturek SJ, Tasler J, Obtulowicz W, Coy DH, Schally AV.
    J Clin Invest; 1976 Jul; 58(1):1-6. PubMed ID: 932201
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Inhibition by somatostatin of pancreatic juice and enzyme secretion and gallbladder contraction in man induced by secretin and cholecystokinin-pancreozymin administration (author's transl)].
    Creutzfeldt W, Lankisch PG, Fölsch UR.
    Dtsch Med Wochenschr; 1975 May 16; 100(20):1135-8. PubMed ID: 1126301
    [Abstract] [Full Text] [Related]

  • 13. Dual actions of glucagon: direct stimulation and indirect inhibition of dog pancreatic secretion.
    Horiuchi A, Iwatsuki K, Ren LM, Kuroda T, Chiba S.
    Eur J Pharmacol; 1993 Jun 11; 237(1):23-30. PubMed ID: 7689468
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of growth hormone releasing factor on pancreatic secretion in vivo and in vitro.
    Konturek SJ, Bilski J, Jaworek J, Mochizuki T, Yanaihara C, Yanaihara N.
    Regul Pept; 1989 Mar 11; 24(3):301-11. PubMed ID: 2469109
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Somatostatin analog, SMS 201-995, inhibits pancreatic exocrine secretion and release of secretin and cholecystokinin in rats.
    Shiratori K, Watanabe S, Takeuchi T.
    Pancreas; 1991 Jan 11; 6(1):23-30. PubMed ID: 1704631
    [Abstract] [Full Text] [Related]

  • 19. MEK inhibits secretin release and pancreatic secretion: roles of secretin-releasing peptide and somatostatin.
    Li JP, Lee KY, Chang TM, Chey WY.
    Am J Physiol Gastrointest Liver Physiol; 2001 May 11; 280(5):G890-6. PubMed ID: 11292597
    [Abstract] [Full Text] [Related]

  • 20. Effect of natural peptide YY on pancreatic secretion and cholecystokinin release in conscious dogs.
    Hosotani R, Inoue K, Kogire M, Tatemoto K, Mutt V, Suzuki T, Rayford PL, Tobe T.
    Dig Dis Sci; 1989 Mar 11; 34(3):468-73. PubMed ID: 2920652
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.